ALX Oncology Holdings Inc.ALXONASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank43
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-104.02M
↓ 18% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-88.04M
Historical baseline
PeriodValueYoY Change
TTM$-104.02M+27.0%
2024$-142.47M+16.3%
2023$-170.28M-33.6%
2022$-127.44M-52.5%
2021$-83.56M-91.4%
2020$-43.66M-127.6%
2019$-19.18M-40.2%
2018$-13.68M-